This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
A recent survey conducted by the HDA Research Foundation revealed few pharmaceutical supply chain stakeholders are prepared to share the transaction data required by the Drug Supply Chain Security Act (DSCSA). Insufficient planning now could lead to supply chain disruptions in the future.
At HDA’s Traceability Online Seminar, attendees will discuss the challenges leading to slow implementation rates as well as solutions and key steps to complete in order to send data, among other DSCSA-related topics.
Register today to join us virtually on November 1–3 to help your company prepare for the compliance deadline on November 27, 2023.
Visit the seminar website for more information. HDA welcomes you to share this event with your customers and trading partners.
The EPCIS Implementation Benchmarking Survey is available as a complimentary download from HDA’s website. To read more about the survey findings and how trading partners should be preparing for the 2023 milestone, view this blog post by HDA’s Justine Freisleben.
Related: HDA Survey Offers Some Troubling DSCSA Prep Results
